Clinical and genetic analyses confirm its pathogenicity, expanding the mutational spectrum of ATP8A2‐related CAMRQ and underscoring the importance of comprehensive genetic testing in rare neurological disorders. Here, ATP8A2 is linked to nervous system disorder.